Development and validation of a liquid chromatographic–tandem mass spectrometric method for the determination of galantamine in human heparinised plasma

This publication has 9 references indexed in Scilit:

• Synthesis of3H-,14C-, and stable-isotope-labelled galantamine
  Journal of Labelled Compounds and Radiopharmaceuticals, 2002
• The Metabolism and Excretion of Galantamine in Rats, Dogs, and Humans
  Drug Metabolism and Disposition, 2002
• Pharmacokinetics and Safety of Galantamine in Subjects with Hepatic Impairment and Healthy Volunteers
  The Journal of Clinical Pharmacology, 2002
• Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: multicentre randomised controlled trial
  BMJ, 2000
• Allosteric modulation of nicotinic acetylcholine receptors as a treatment strategy for Alzheimer's disease
  European Journal of Pharmacology, 2000
• LC detectors: evaluation and practical implications of linearity
  Analytical Chemistry, 1989
• Reversed-phase liquid chromatography for the determination of galanthamine and its metabolites in human plasma and urine
  Journal of Chromatography B: Biomedical Sciences and Applications, 1987
• High-performance liquid chromatographic determination of galanthamine, a long-acting anticholinesterase drug, in serum, urine and bile
  Journal of Chromatography B: Biomedical Sciences and Applications, 1982
• Interaction of reversible inhibitors with catalytic centers and allosteric sites of cholinesterases
  Bulletin of Experimental Biology and Medicine, 1976